Options
Interleukin-6 (IL-6), Tumor Necrosis Factor α (TNF α), and C-reactive Protein (CRP) serum levels in new-borns with sepsis
Journal
Clinical Neonatology
Date Issued
2000-12-01
Author(s)
Abstract
Neonatal sepsis is a common and life-threatening disorder, particularly among preterm infants. Initiation of antibiotic therapy is frequently delayed because the initial clinical signs of sepsis are usually non-specific and there are no reliable early laboratory indicators. In order to evaluate the usefulness of early diagnostic testing for neonatal sepsis, including interleukin-6 (IL-6), and tumor necrosis factor α (TNF- α), in combination with C-reactive protein (CRP), a later sepsis marker, we investigated the serum levels of TNF- α, IL-6 and CRP in neonates with sepsis before and after antibiotic treatment. Our data showed that higher IL-6, TNF- α, and CRP serum levels were found in the sepsis group than in the control group (p<0.001) on admission. These IL-6, TNF- α, and CRP serum levels decreased significantly after antibiotic treatment. We conclude that sequential determination of IL-6, TNF- α, and CRP serum levels is useful in early detection of neonatal sepsis and in assessing the efficacy of antimicrobial therapy.
Type
journal article